Selective degradation of splicing factor CAPERα by anticancer sulfonamides

作者: Taku Yoshida , Miyuki Mabuchi , Akito Tanaka , Takashi Owa , Taisuke Uehara

DOI: 10.1038/NCHEMBIO.2363

关键词:

摘要: Target-protein degradation is an emerging field in drug discovery and development. In particular, the substrate-receptor proteins of cullin-ubiquitin ligase system play a key role selective protein degradation, which essential component anti-myeloma activity immunomodulatory drugs (IMiDs), such as lenalidomide. Here, we demonstrate that series anticancer sulfonamides NSC 719239 (E7820), indisulam, 339004 (chloroquinoxaline sulfonamide, CQS) induce proteasomal U2AF-related splicing factor coactivator activating protein-1 estrogen receptors (CAPERα) via CRL4DCAF15 mediated ubiquitination human cancer cell lines. Both CRISPR-Cas9-based knockout DCAF15 single amino acid substitution CAPERα conferred resistance against sulfonamide-induced cell-growth inhibition. Thus, these represent chemical probes for disrupting function designate DCAFs promising targets promoting therapy.

参考文章(45)
Jing Lu, Yimin Qian, Martha Altieri, Hanqing Dong, Jing Wang, Kanak Raina, John Hines, James D. Winkler, Andrew P. Crew, Kevin Coleman, Craig M. Crews, Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 Chemistry & Biology. ,vol. 22, pp. 755- 763 ,(2015) , 10.1016/J.CHEMBIOL.2015.05.009
Daniel P Bondeson, Alina Mares, Ian E D Smith, Eunhwa Ko, Sebastien Campos, Afjal H Miah, Katie E Mulholland, Natasha Routly, Dennis L Buckley, Jeffrey L Gustafson, Nico Zinn, Paola Grandi, Satoko Shimamura, Giovanna Bergamini, Maria Faelth-Savitski, Marcus Bantscheff, Carly Cox, Deborah A Gordon, Ryan R Willard, John J Flanagan, Linda N Casillas, Bartholomew J Votta, Willem den Besten, Kristoffer Famm, Laurens Kruidenier, Paul S Carter, John D Harling, Ian Churcher, Craig M Crews, Catalytic in vivo protein knockdown by small-molecule PROTACs Nature Chemical Biology. ,vol. 11, pp. 611- 617 ,(2015) , 10.1038/NCHEMBIO.1858
Jan Krönke, Emma C. Fink, Paul W. Hollenbach, Kyle J. MacBeth, Slater N. Hurst, Namrata D. Udeshi, Philip P. Chamberlain, D. R. Mani, Hon Wah Man, Anita K. Gandhi, Tanya Svinkina, Rebekka K. Schneider, Marie McConkey, Marcus Järås, Elizabeth Griffiths, Meir Wetzler, Lars Bullinger, Brian E. Cathers, Steven A. Carr, Rajesh Chopra, Benjamin L. Ebert, Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS Nature. ,vol. 523, pp. 183- 188 ,(2015) , 10.1038/NATURE14610
Jarrett D Egertson, Brendan MacLean, Richard Johnson, Yue Xuan, Michael J MacCoss, Multiplexed peptide analysis using data-independent acquisition and Skyline Nature Protocols. ,vol. 10, pp. 887- 903 ,(2015) , 10.1038/NPROT.2015.055
G. E. Winter, D. L. Buckley, J. Paulk, J. M. Roberts, A. Souza, S. Dhe-Paganon, J. E. Bradner, Phthalimide conjugation as a strategy for in vivo target protein degradation Science. ,vol. 348, pp. 1376- 1381 ,(2015) , 10.1126/SCIENCE.AAB1433
Naoko Hata Sugi, Norihiro Ueda, Kentaro Yoshimatsu, Takashi Owa, Junichi Kamata, Shinichi Hamaoka, Yoichi Ozawa, Kazumasa Nara, Toshiaki Wakabayashi, Taro Semba, Yuji Yamamoto, Naoko Tsukahara-Tamai, Tadashi Okabe, Yasuhiro Funahashi, Toru Haneda, Akihiko Tsuruoka, Masahiro Yonaga, Keiko Takahashi, Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium. Cancer Research. ,vol. 62, pp. 6116- 6123 ,(2002)
Andreas Schroeder, Odilo Mueller, Susanne Stocker, Ruediger Salowsky, Michael Leiber, Marcus Gassmann, Samar Lightfoot, Wolfram Menzel, Martin Granzow, Thomas Ragg, The RIN: an RNA integrity number for assigning integrity values to RNA measurements BMC Molecular Biology. ,vol. 7, pp. 3- 3 ,(2006) , 10.1186/1471-2199-7-3
A Sveen, S Kilpinen, A Ruusulehto, R A Lothe, R I Skotheim, Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes Oncogene. ,vol. 35, pp. 2413- 2427 ,(2016) , 10.1038/ONC.2015.318
Tanios S. Bekaii-Saab, Amir Mortazavi, Lee G. Hicks, Mark Zalupski, Robert J. Pelley, Kenneth K. Chan, Eric H. Kraut, A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC). Investigational New Drugs. ,vol. 24, pp. 343- 346 ,(2006) , 10.1007/S10637-005-4827-3